William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Starts Kardigan Inc (KARD) at Outperform
-
William Blair Starts Arcus Biosciences (RCUS) at Outperform
-
William Blair Starts Faeth Therapeutics (FTH) at Outperform
-
William Blair Starts Rhythm Pharmaceuticals (RYTM) at Outperform
-
William Blair Starts WAVE Life Sciences (WVE) at Outperform
-
William Blair Starts Palvella Therapeutics (PVLA) at Outperform
-
William Blair Starts Ideaya Biosciences (IDYA) at Outperform
-
William Blair Starts Immunome Inc. (IMNM) at Outperform
-
William Blair Starts Revolution (RVMD) at Outperform
-
William Blair Starts Edgewise Therapeutics (EWTX) at Outperform
-
William Blair Starts Tango Therapeutics Inc. (TNGX) at Outperform
-
William Blair Starts Cytokinetics (CYTK) at Outperform
-
William Blair Downgrades Clarivate Analytics (CCC) to Market Perform
-
William Blair launches first ETFs on NYSE for international markets
-
William Blair Starts Marex Group PLC (MRX) at Outperform
-
William Blair Resumes Jasper Therapeutics (JSPR) at Outperform
-
PSP Capital sells StormTrap to Advanced Drainage Systems for $530M
-
Form CERT William Blair ETF Trust
-
William Blair on SpaceX (SPCX): 'Indoor Coverage Problem Closer to Solved?'
-
William Blair Downgrades Alignment Healthcare Inc (ALHC) to Market Perform
-
William Blair: 'One wild card could be a potential sale of Starbucks Japan, which could help fund a Chipotle acquisition'
-
William Blair Downgrades Latham Group Inc. (SWIM) to Market Perform
-
William Blair Reiterates Market Perform Rating on SiteOne Landscape Supply (SITE)
-
William Blair Downgrades Option Care Health (OPCH) to Market Perform
-
William Blair: 'view BridgeBio as becoming a core smidcap biotech holding'
-
AST SpaceMobile shares jump on carrier test wins
-
William Blair on HubSpot Inc (HUBS): 'the multiple is not demanding, HubSpot faces uncertainty ahead'
-
William Blair Starts Lattice Semiconductor (LSCC) at Outperform
-
William Blair Starts Revvity Inc (RVTY) at Outperform
-
William Blair Reiterates Market Perform Rating on AST Spacemobile (ASTS)
-
Advanced Drainage Systems to acquire StormTrap for $530 million
-
William Blair Starts Sable Offshore Corp. (SOC) at Outperform
-
William Blair: 'We expect this news to add to an already burdensome (and ongoing) overhang for both EFX and TRU shares'
-
William Blair on Tesla (TSLA): 'Model S/X sunset and Cybertruck remains at low volumes'
-
William Blair Reiterates Market Perform Rating on Backblaze Inc (BLZE)
-
William Blair Adjusts October Analyst Conviction List Names
-
William Blair on Micron (MU): 'Signals Persistent Memory Undersupply Through 2028 in Strong End to Fiscal Year'
-
Hormel Foods to acquire Brakebush Brothers for $1.055B
-
William Blair Starts CoreWeave (CRWV) at Outperform
-
William Blair Starts Nebius Group (NBIS) at Outperform
-
Accelevation prices IPO at $18 per share on Nasdaq
-
Form 497K William Blair ETF Trust
-
Form 497K William Blair ETF Trust
-
Form 497K William Blair ETF Trust
-
Form 497 William Blair ETF Trust
-
AAR agrees to buy 65% stake in MRO Holdings for $4 billion
-
Viking Therapeutics raises $575M through stock and note offerings
-
William Blair Reiterates Market Perform Rating on On Holding AG (ONON)
-
Form 8-A12B William Blair ETF Trust
-
William Blair Downgrades Lifecore Biomedical (LFCR) to Market Perform


